All posts by imreal

University of California Health launches Long COVID education series to expand access to care


“By educating, equipping and empowering more providers in the battle against the very real impact of Long COVID, we are helping expand access to care for this condition,” said University of California Health’s Vice President and Chief Clinical Strategy Officer Anne Foster, M.D., MPH, FACOG.

University of California Health has created a video education series to inform and educate health care providers about best practices and the latest research on screening, managing symptoms and making specialty referrals for patients with post-COVID symptoms.

The COVID-19 pandemic has been a mass disabling event that has led to long-term consequences for patients, health care providers, and the nation’s system of health care, especially in medically underserved communities. “In California alone, there may be an estimated 2 million Long COVID patients, and it’s likely that the impact from this condition may increase already existing health inequities,” said University of California Health’s Vice President and Chief Clinical Strategy Officer Anne Foster, M.D., MPH, FACOG. “By educating, equipping, and empowering more providers in the battle against the very real impact of Long COVID, we are helping expand access to care for this condition.”

With potentially 1 in 5 COVID-19 patients affected by Long COVID – also known as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), it is urgent for more providers to keep current on what is known about the condition and its impacts, added Foster.

Sharing academic health system knowledge broadly

The UC education series brings together the knowledge and learnings from 12 academic health professionals across UC’s system, including faculty and clinicians from UC Davis, UCI, UCLA, UC San Diego, and UCSF. Delivered online via video, the content is available in individual video lectures or as a no-cost Continuing Medical Education (CME) course.* State, national and global distribution is underway.

The modules include an overview of PASC/Long COVID, as well as information on the evaluation of the primary care patient with PASC/Long COVID. The specialty areas included in the modules are: pulmonology, neurology, psychiatry/behavioral health, rheumatology, cardiology, pediatrics, preventive and lifestyle/integrative medicine, emergency medicine, and health disparities.

About University of California Health

University of California Health comprises six academic health centers, 20 health professional schools, a Global Health Institute and systemwide services that improve the health of patients and the University’s students, faculty, and employees. All of UC’s hospitals are ranked among the best in California and its medical schools and health professional schools are nationally ranked in their respective areas. More information and news from University of California Health is available on its website.

———

*About the Continuing Medical Education course:

Accreditation Statement

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this enduring material activity for a maximum of *6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

(*When all 7 modules are completed. Please refer to the credit designation statement for each module’s credit amount)

Share article on social media or email:

HempLucid Announces Natural Functional Mushroom Gummies


HempLucid Functional Mushroom Gummies for Stress

Functional mushrooms and CBD combine in great-tasting gummies to ease the day-to-day stress.

“Our customers optimize their life and their performance naturally – functional mushrooms and hemp are powerful partners in their restorative journey,” said HempLucid CEO Nathan Beckham.

HempLucid, a leading provider of plant-based wellness supplements, announces its newest addition: functional mushrooms combined with hemp guaranteed to improve focus, sleep, and stress.

“Our customers optimize their life and their performance naturally – functional mushrooms and hemp are powerful partners in their restorative journey,” said HempLucid CEO Nathan Beckham.

The vegan, gluten-free mushroom gummy product line includes Reishi, known for its antioxidant effects, and Lion’s Mane found to improve mood and sleep maladies. The mushrooms work in concert with organic hemp cannabinoids like CBN, known for their calming effects, Delta-9, a mood lifter, and CBD, well known to reduce inflammation.

“We are in a new era of functional wellness,” said Beckham. “Mushrooms and hemp are the heroes of healing, and we’re proud to bring them to consumers across the United States,” he continued.

The bio-functional Mushroom Gummies line includes:

Sleep Mushroom Gummies: Reishi mushroom, Valerian Root, and Lemon Balm combine with calming organic hemp-extracted CBN and CBD. Melatonin-free.

Stress Mushroom Gummies: adaptogenic mushroom blend including Lion’s Mane and Reishi combined with organic hemp extracted CBD and Delta-9 to reduce stress without leaving you in a fog. May help improve your body’s resilience to stress.

Focus Mushroom Gummies: Lion’s Mane combined with organic hemp-extracted CBG and CBD to elevate focus with nootropic ingredients.

The new Mushroom Gummies all come with a 30-day money-back guarantee.

The Mushroom Gummies are an addition to HempLucid’s best-selling Mushroom Stacks, capsules with immune, and immune support. The entire mushroom line is made in the USA.

The Mushroom Gummies are available on hemplucid.com.

About HempLucid

HempLucid, is a leading provider of premium wellness products, including mushroom and CBD supplements. By celebrating and empowering others to heal in harmony with nature, HempLucid’s mission is to create innovative products that inspire others to become aware of their healing path. HempLucid’s commitment to exemplary products and extraordinary corporate responsibility is driven by the company’s core. HempLucid views healing and wellness through a holistic lens and stands on it. The company’s core values of quality, education, self-worth and connection, compassion, and revolution. Current product offerings include plant-based edibles, topicals, tinctures, and capsules. HempLucid is based in Provo, Utah and founded by Nathan Beckham and Chase Hudson in 2016.

For more information: hemplucid.com

Instagram: @hemplucid

Share article on social media or email:



APEX Biologix Announces New, Industry-Leading XCELL Protein Concentrator System


APEX Biologix Announces New, Industry-Leading XCELL Protein Concentrator System

APEX is proud to be able to continue to be the one source for high-quality autologous biologic products.

APEX Biologix, a leader in innovative biologic medicine, announced their exclusive industry-leading XCELL PC (Protein Concentrator) Kit, now available for purchase. Utilizing components of platelet-poor plasma has become one of the fastest growing segments of regenerative medicine. The advanced features of the XCELL PC kit allow for increased concentration of a variety of beneficial proteins, with easier use and reduced processing time compared to earlier generation blood and plasma filters on the market.

Through this innovative design, significant increases are attainable in the retention of platelet-derived growth factors, A2M (Alpha 2 Macroglobulin), IRAP, fibrinogen, and other cytokines, all of which have demonstrated beneficial in reduction of inflammation and pain and/or the suppression of joint degeneration by inactivation of destructive enzymes.

“With nearly 30 million Americans suffering from osteoarthritis, physicians desperately need tools to promote healing and reverse painful degeneration. We are excited to announce the launch of the XCELL Protein Concentration filter with its revolutionary design to maximize recovery of a wide range of proteins found in plasma. APEX is proud to be able to continue to be the one source for high-quality autologous biologic products.” – Troy Openshaw, President

The new XCELL PC filter includes preassembled connectors and caps, which ensure increased sterility while improving convenience. With a patented new membrane material, a larger range of protein (based on their size) can be recovered during processing. This new filter also removes more water, resulting in a customizable concentration and final product volumes. Additionally, the new XCELL PC is manufactured in a “primed” configuration, which significantly increases recoverable volume, thereby minimizing loss of proteins that would otherwise be bound to the membrane filter.

APEX strives to continuously improve products for physicians and has become the market leader in regenerative medicine. For more information on their products and how their biologic innovations are impacting patients and improving quality of life, visit apexbiologix.com or message info@apexbiologix.com.

About APEX Biologix

APEX Biologix is an emerging industry leader in orthobiologics. The company is dedicated to the science and research of innovative biologic medicine and its potential, while supplying physicians with the best products and education available to treat their patients and improve quality of life.

Media Contact:

Sean Woodward

844-897-4910

info@apexbiologix.com

Share article on social media or email:

Fortero Launches Online Diagnostics Service Specializing in Thinning Hair Treatments


Your Fortero package is shipped free of charge in discreet, non-identifying packaging. You’ll get it quickly and directly, along with some helpful info for your hair regrowth journey.

The Perfect Solution For You

From the comfort of home, users can receive a diagnosis for thinning hair and have an individualized prescription delivered right to home.

On November 1, 2022, SEISEIDOU AMERICA, INC. began an online diagnosis service for hair loss treatments in the United States.

This service allows to receive an online diagnosis from the comfort of home and an individualized prescription, which is sent directly (with no added charges for shipping). In addition to the safe and secure online diagnosis procedure, users can experience significant hair regrowth in as little as three months with the help of a licensed clinician, who will create a personally tailored treatment plan for each user.

The goal of SEISEIDOU AMERICA, INC. is to solve clients’ hair loss problems. Today, two out of three people in their thirties suffer from thinning hair. Want to accelerate hair regrowth and hair growth in general? Do medicated shampoos have no noticeable effects? Hair lacks bounce and body? If so, Fortero RX can help. Fortero wants all men suffering from thinning hair to regain their vitality and confidence!

Fortero RX is the perfect solution. Regardless of age, lifestyle, or degree of hair loss, this product offers the most efficient and approved formula to beat genes and improve thinning hair. To start the process, people will be asked to complete a short questionnaire. Based on responses, the team of experts at Fortero will analyze symptoms and determine the best medication. Simply fill out the questionnaire at home and receive prescribed medication.

The following is an introduction to the medical minds behind Fortero RX.

Fortero is proud of the medical professionals that support their formula as they lead the charge in helping men reclaim their former glory.

Dr. Candace Chumley INTERNAL MEDICINE

A physician who focuses on the diagnosis and treatment of conditions, Dr. Candace Chumley specializes in both acute and chronic hair loss. She will work with directly to help maintain optimal health as regrow lost hair.

Tod Work, NP PAIN MANAGEMENT

Tod leads pain management team to make sure that every client is healthy, resilient, and using Fortero RX according to the plan prescribed.

Dr. David Young ACTIVE AGING AND PEPTIDES

Dr. Young leads Active Aging and Peptide program, which was established to optimize physical, social, and mental well-being as a Fortero users.

Find the plan that is right. Fortero RX takes pride in formulating the perfect hair restoration treatment based on the specific needs of each individual.

Click below and take a short quiz. Even if don’t buy a product today, get a clear understanding of scalp’s needs and the causes of hair loss.

Many users have actually succeeded in regrowing their hair. Reading through some testimonials will give users an idea of the actual effect of Fortero’s services without needing a highly detailed explanation.

Results take different amounts of time for different users, though most men see significant results in just three to six months.

The Fortero team believes that healthcare is a long-term journey and not a one-off experience. With a Fortero RX subscription, users will receive unlimited clinician support and will not have to worry about running out of treatment anymore. In addition, users can skip deliveries or cancel anytime.

Order quickly and discreetly, right from phone. Delivery is fast and free. Plus, users can cancel anytime.

Fortero RX is available for diagnosis and purchase 24 hours a day, 7 days a week.

For other support inquiries, please contact at: support@fortero.com

+1 (888) 391-5982

Share article on social media or email:

Impact Advisors Ranks No. 5 on Modern Healthcare’s Largest IT Consulting Firms List




We are so proud of the growth our firm has seen over the last several years and we credit our success to our associates who are dedicated to providing high-value services and high-quality results day in and day out for our clients.

Impact Advisors, a leading healthcare consultancy providing strategy, operations, revenue cycle, and technology services, has been ranked No. 5 on Modern Healthcare’s Largest IT Consulting Firms list for 2022 making it the third time the firm has been recognized among the key players in the industry.

Modern Healthcare began ranking organizations in 2019 and this year chose only nine consulting firms from across the country based on 2021 revenue, health IT contracts, and number of employed healthcare consultants. The complete listing appears in the November issue of Modern Healthcare.

“We are so proud of the growth our firm has seen over the last several years and we credit our success to our associates who are dedicated to providing high-value services and high-quality results day in and day out for our clients,” said Pete Smith, founder and managing partner of Impact Advisors. “Our clients have a continued need for support with analytics, digital health, security, M&A, operational improvement, and optimization, just to name a few, and we have broadened and enhanced our service offerings over the years to meet the demands of the industry.”

Impact Advisors was founded in 2007 to become the nation’s premier healthcare consulting firm with a sole focus on delivering quality service to clients. The firm is a trusted partner among the industry’s leading healthcare organizations with a solid reputation that continues to propel its consistent annual growth, tempered by hiring only the best employees in the industry.

The firm has also been featured on Modern Healthcare’s Largest Revenue Cycle Management Firms list, Largest Healthcare Management Consulting Firms list and on its Best Places to Work in Healthcare list.

About Impact Advisors

Impact Advisors is a nationally recognized healthcare management consulting and technology services firm that is solving some of the toughest challenges in the industry by delivering strategic advisory, technology implementation and operational improvement services. Our comprehensive suite of strategic planning, digital health, clinical optimization and revenue cycle services spans the lifecycle of our clients’ needs. Our experienced team has a powerful combination of clinical, revenue, operations, consulting and information technology experience. The firm has earned several prestigious industry and workplace awards including Best in KLAS® for 15 consecutive years, Healthcare Informatics HCI 100, Crain’s Chicago Business Fast Fifty, as well as “best place to work” awards from: Modern Healthcare, Consulting Magazine, Becker’s Hospital Review and Achievers. For more information about Impact Advisors, visit http://www.impact-advisors.com.

Share article on social media or email:

Translational Research in Oncology — Innovations in Model Development, Upcoming Webinar Hosted by Xtalks


Innovative approaches to model development can address many shortcomings of legacy models.

To develop the next generation of targeted cancer therapies, researchers need cancer models that can stand in as true proxies for human disease. Traditional research models commonly used in commercial applications have a place in screening and can provide directional information about potential therapeutic responses. However, they do not replicate the heterogenous biology and complex network of dysregulated pathways that characterize real-life human tumors. In fact, most models used in preclinical drug development fail to address the importance of tumor microenvironment, despite its well-established role in druggability and immune response. Translational research in oncology can greatly benefit from improvements to these models.

Innovative approaches to model development can address many shortcomings of legacy models. What’s more, both in vitro and in vivo test systems can now be customized to account for the myriad of clinical scenarios (prior treatment, radiotherapy, acquired resistance, metastases) that may ultimately determine clinical response to a given experimental therapy.

Translational research success is largely dependent upon selecting — or sometimes custom-developing — the most appropriate preclinical model to assess a candidate’s therapeutic response. During this webinar, the featured speakers will review current literature on cell culture, organoids/spheroids and various types of in vivo mouse models and discuss emerging techniques for developing more clinically relevant models of cancer.

Register to learn about the innovations in preclinical model development for translational research in oncology.

Join experts from Certis Oncology Solutions, Jonathan Nakashima, PhD, Chief Scientific Officer; Jantzen Sperry, PhD, Senior Director, Scientific Operations; and Rajeev Shrimali, PhD, Senior Director, Immuno-Oncology R&D, for the live webinar on Wednesday, December 14, 2022, at 2pm EST (11am PST).

For more information, or to register for this event, visit Translational Research in Oncology — Innovations in Model Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

ARCH Medical Solutions acquires Nicholas Precision Works


NPW owner since 2014 and founder of the former NG Instruments, Tony Nicholas sees the company’s move as the best next step for his team. “For the skilled staff, our customers and all of us at NPW, this is the culmination of our investments in people and equipment.” said Nicholas

ARCH Medical Solutions Corp. (“ARCH”) has acquired Nicholas Precision Works (“NPW”) of North Manchester, Indiana, the company announced today. As a contract manufacturing company specializing in precision grinding, NPW provides surgical cutting tools and precision ground instruments to the medical industry. Founded by Tony Nicholas in 2014, NPW has established a state-of-the-art manufacturing facility, supporting the technical development and manufacturing needs of medical OEMs bringing new and innovative products to market. In conjunction with the acquisition, NPW and the existing ARCH precision grinding capabilities at its OrthoGrind manufacturing facility in Fort Wayne, Indiana, will form the new ARCH Medical Grinding business unit.

Paul Barck, Divisional President of ARCH Medical Solutions, welcomes the surgical instrument grinding expertise and extensive medical device manufacturing experience NPW brings.

“Joining forces with Tony and the NPW team is exciting for those of us at ARCH Medical Solutions and our customers,” Barck said. “NPW has invested in first-class equipment, processes, facilities and team members, demonstrating a commitment to create and operate a world-class medical grinding operation. Tony and the team at NPW have earned a stellar reputation among leading OEMs for having the engineering and manufacturing process know-how required to bring new products to market—fast. ARCH has provided its customers ground and fluted instruments since inception, although through this acquisition and the newly formed ARCH Medical Grinding entity, we are now positioned to have the fully integrated capabilities and scale that will offer our customers industry-leading quality and lead times for their new and innovative product needs.”

John Ruggieri, Senior Vice President of Business Development at ARCH Medical Solutions, envisions an elevated customer experience with the addition of NPW and its unique services.

“The capabilities developed at NPW are exactly the type of innovations our customers are continually seeking,” Ruggieri said. “NPW strengthens our ability to provide progressive and innovative customer support. Having NPW as a part of ARCH will provide our customers with the highest-quality cutting instruments for the orthopedic and medical device markets and allow them to explore cost-efficient manufacturing solutions with accelerated lead times.”

NPW owner since 2014 and founder of the former NG Instruments, Tony Nicholas sees the company’s move as the best next step for his team and longtime customers.

“For the skilled staff, our customers and all of us at NPW, this is the culmination of our investments in people and equipment, our expertise in grinding devices for the medical industry, and our dedication to engineering and design support for our customers,” said Nicholas, who will stay in North Manchester as President of ARCH Medical Grinding. “We are proud to be a part of a larger organization with others who share our dedication to meeting customers’ needs. It is exciting to think of the possibilities the future is sure to bring.”

About ARCH Medical Solutions

ARCH Medical Solutions, a Jordan Company platform company based in metro Detroit, precision manufactures high-quality medical components, parts, instruments, devices, and implants for a range of life-changing medical applications. ARCH Medical Solutions has multiple FDA-registered facilities across the country serving the orthopedics, surgical robotics, dental, and life sciences markets. The teams at ARCH Medical Solutions are metalworking professionals with industry-leading tight-tolerance manufacturing expertise. ARCH Medical Solutions provides innovative and practical solutions to the complex manufacturing challenges of its customers that lead to better patient outcomes. Improving peoples’ lives. We have a part in that.

Learn more at arch-medical.com.

Share article on social media or email:

Can Alzheimer’s disease be delayed or stopped before the symptoms…


The AHEAD clinical trial will assess whether a new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. The Glenn Biggs Institute for…

(PRWeb December 02, 2022)

Read the full story at https://www.prweb.com/releases/can_alzheimers_disease_be_delayed_or_stopped_before_the_symptoms_begin_a_new_clinical_trial_strives_to_find_answers/prweb19053084.htm

AZ Top Docs Has Reviewed and Approved Gary Knighton, D.O. For 2022


Dr. Gary Knighton

Dr. Gary Knighton

Bariatrician, Gary Knighton, D.O. of Arizona Medical Weight Loss has been reviewed and approved by AZ Top Docs for 2022.

Dr. Knighton, a long standing member of the Obesity Medicine Association (formerly the American Society of Bariatric Physicians) uses a multi-faceted approach, combining a balance of nutrition, activity, proper vitamin supplementation, and medications to help his patients shed the extra weight.

Dr. Knighton believes that making life changes can be downright enjoyable, when your support team is the staff at Arizona Medical Weight Loss.

“When you come in for your visit, regardless of how you’re feeling, we promise you’ll leave with a smile on your face, feeling better about yourself, and looking great,” he says.

Dr. Knighton is also a member of the American Medical Association, the American Osteopathic Association, and the Arizona Osteopathic Medical Association.

To learn more about Dr. Gary Knighton and his practice, Arizona Medical Weight Loss please visit: https://aztopdocs.com/doctors/drgaryknighton/

About Us

AZ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in Arizona online in an easy to use format. AZ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

AZ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, e-mail us at info@AZTopDocs.com and/or visit http://www.AZTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:

Nacha’s Payments Innovation Alliance Releases New Guide Explaining and Simplifying Voice Payments Processing Using the ACH Network


report cover

Nacha releases new conversational payments resource.

“Over the past two years, Nacha has updated its Operating Rules and Guidelines to reflect emerging technology. Voice Payments: Guide to Nacha’s Operating Rules assists by identifying the specific provisions that apply in a variety of use cases,” said Jennifer West, AAP, APRP, Nacha.

Nacha’s Payments Innovation Alliance has created a new resource aimed at financial institutions, billers and payments processors. Voice Payments: Guide to Nacha’s Operating Rules identifies the most common conversational payments use cases, offers answers to frequently asked questions and assists in determining the Standard Entry Class (SEC) Codes for consumer bill payment use cases using voice-assisted devices or smart speakers for ACH payments.

“Over the past two years, Nacha has updated its Operating Rules and Guidelines to reflect emerging technology, including voice payments within the ACH Network. Voice Payments: Guide to Nacha’s Operating Rules assists by identifying the specific provisions that apply in a variety of use cases,” said Jennifer West, AAP, APRP, Senior Director, Payments Innovation Alliance, Nacha. “The publication offers important guidance to banks, credit unions, billers and payment processors offering conversational ACH payment options.”

Written by members of the Alliance’s Conversational Payments and Cybersecurity Response Project Teams, the guide completes a series of conversational payments-focused Executive Briefings, including Voice Payments: An Introduction and Overview; A Deep Dive into the Technology Behind Voice Payments; and Voice Payments: Contractual Considerations for Financial Institutions. These publications provide an introductory look at conversational payments, an in-depth look at the technology allowing voice payments to work and offer legal and risk mitigation resources for financial institutions seeking to implement voice payment capabilities and applications (skills) through smart devices. In addition, the Project teams also published Unwrapping Smart Speakers, providing best practices to protect consumers from vulnerabilities of cyber threats and unwanted data sharing in their homes.

Nacha’s Payments Innovation Alliance is a diverse membership organization of financial institutions of all sizes, fintechs, solution providers, corporations, law firms and others that seeks to grow and advance payments through innovation to better meet the needs of the modern ACH Network and the evolving payments industry worldwide. To download a copy of Alliance Executive Briefings, visit http://www.nacha.org/content/voice-payments-executive-briefing-series.

About Nacha

Nacha governs the thriving ACH Network, the payment system that drives safe, smart, and fast Direct Deposits and Direct Payments with the capability to reach all U.S. bank and credit union accounts. More than 29 billion ACH Network payments were made in 2021, valued at close to $73 trillion. Through problem-solving and consensus-building among diverse payment industry stakeholders, Nacha advances innovation and interoperability in the payments system. Nacha develops rules and standards, provides industry solutions, and delivers education, accreditation, and advisory services.

Share article on social media or email: